315 related articles for article (PubMed ID: 8608259)
1. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
2. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
Prosper F; Stroncek D; Verfaillie CM
Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
[TBL] [Abstract][Full Text] [Related]
5. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
Steen R; Tjønnfjord GE; Egeland T
J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
[TBL] [Abstract][Full Text] [Related]
9. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
[TBL] [Abstract][Full Text] [Related]
10. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
Möhle R; Haas R; Hunstein W
J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
[TBL] [Abstract][Full Text] [Related]
11. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
MacVittie TJ; Farese AM; Davis TA; Lind LB; McKearn JP
Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
[TBL] [Abstract][Full Text] [Related]
13. Neutrophilic cell production by combination of stem cell factor and thrombopoietin from CD34(+) cord blood cells in long-term serum-deprived liquid culture.
Sawai N; Koike K; Ito S; Mwamtemi HH; Kurokawa Y; Kinoshita T; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Miyazaki H; Kato T; Komiyama A
Blood; 1999 Jan; 93(2):509-18. PubMed ID: 9885212
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
[TBL] [Abstract][Full Text] [Related]
15. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
[TBL] [Abstract][Full Text] [Related]
17. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
18. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
[TBL] [Abstract][Full Text] [Related]
19. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
20. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
